Lupin Ltd has announced that the US Court has lifted the Temporary Restraining Order and denied Astellas' request for a preliminary injunction on Mirabegron ER Tablets. Thereafter, shipment of the product has now resumed.
Mirabegron ER Tablets, 25 mg are a generic equivalent of Myrbetriq® Extended-Release Tablets, 25 mg of Astellas Pharma Global Development, Inc., and were launched by Lupin in April 2024.
Shares of Lupin Limited was last trading in BSE at Rs. 1615.80 as compared to the previous close of Rs. 1610.55. The total number of shares traded during the day was 27302 in over 1910 trades.
The stock hit an intraday high of Rs. 1630.05 and intraday low of 1593.55. The net turnover during the day was Rs. 44138072.00. |
